| Design and monitoring of multi‐arm multi‐stage clinical trials P Ghosh, L Liu, P Senchaudhuri, P Gao, C Mehta Biometrics 73 (4), 1289-1299, 2017 | 51 | 2017 |
| Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study MN Landis, SR Smith, G Berstein, G Fetterly, P Ghosh, G Feng, V Pradhan, ... British Journal of Dermatology 189 (1), 33-41, 2023 | 20 | 2023 |
| Brepocitinib, zimlovisertib, and ropsacitinib in hidradenitis suppurativa AB Kimball, E Peeva, S Forman, A Moiin, S Khattri, ML Porter, ... NEJM evidence 3 (3), EVIDoa2300155, 2024 | 15 | 2024 |
| Adaptive multiarm multistage clinical trials P Ghosh, L Liu, C Mehta Statistics in Medicine 39 (8), 1084-1102, 2020 | 13 | 2020 |
| Robust group sequential designs for trials with survival endpoints and delayed response P Ghosh, R Ristl, F König, M Posch, C Jennison, H Götte, A Schüler, ... Biometrical Journal 64 (2), 343-360, 2022 | 10 | 2022 |
| System & method for computationally efficient and statistically robust design of multi-arm multi-stage experiments PK Ghosh, L Liu, P Senchaudhuri, C Mehta, P Gao, S Herbert US Patent App. 15/594,024, 2017 | 8 | 2017 |
| Exact inference for adaptive group sequential designs C Mehta, L Liu, P Ghosh, P Gao Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016 39 …, 2019 | 4 | 2019 |
| Performance of Modified ALMS and BLISS Criteria with Standard of Care Treatment in Two US Health Care Systems A Khosroshahi, D Tong, G Bao, J Al‐Naqeeb, P Ghosh, E Peeva, ... Arthritis Care & Research 75 (7), 1423-1433, 2023 | 3 | 2023 |
| Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study Y Yamaguchi, E Peeva, R Adiri, P Ghosh, L Napatalung, I Hamzavi, ... Journal of the American Academy of Dermatology, 2024 | | 2024 |
| Validation of the Peak Pruritus‐Numerical Rating Scale in patients with chronic plaque psoriasis: results from a phase 2 study ZD Draelos, AG Bushmakin, P Ghosh, J Xenakis, JC Cappelleri International Journal of Dermatology 63 (12), e375-e382, 2024 | | 2024 |
| 648-Response to ritlecitinib with or without narrow band ultraviolet B (nbUVB) add-on therapy in patients with active non-segmental vitiligo (NSV) Y Yamaguchi, E Peeva, R Adiri, P Ghosh, L Napatalung, I Hamzavi, ... British Journal of Dermatology 191 (Supplement_2), ljae266. 027, 2024 | | 2024 |
| Response to ritlecitinib with or without narrow band ultraviolet B (nbUVB) add-on therapy in patients with active non-segmental vitiligo (NSV) Y Yamaguchi, E Peeva, R Adiri, P Ghosh, L Napatalung, IH Hamzavi, ... | | 2024 |
| Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study … MN Landis, SR Smith, G Berstein, G Fetterly, P Ghosh, G Feng, V Pradhan, ... BRITISH JOURNAL OF DERMATOLOGY 189 (5), E81-E81, 2023 | | 2023 |
| Performance of Modified Treatment Criteria with Standard of Care in Two US Health Care Systems A Khosroshahi, D Tong, G Bao, J Al-Naqeeb, P Ghosh, E Peeva, ... ARTHRITIS CARE & RESEARCH, 2023 | | 2023 |
| Design of Adaptive Multiarm Multistage Clinical Trials P Ghosh Boston University, 2018 | | 2018 |
Cyrus MehtaAdjunct Professor of Biostatistics, Harvard Universitبريد إلكتروني تم التحقق منه على cytel.com